ArticleJournal of bone oncology2022

Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial.

Jiaji Yue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.